| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The Journal of Immunology, Vol 148, Issue 6 1731-1736, Copyright © 1992 by American Association of Immunologists
ARTICLES |
CD Richards, TJ Brown, M Shoyab, H Baumann and J Gauldie
Department of Pathology, McMaster University, Hamilton, Ontario, Canada.
Acute inflammation is characterized by increased liver output of acute phase proteins (APP). Several cytokines including IL-6, leukemia inhibitory factor, and IL-11 are capable of stimulating APP synthesis by hepatocytes and hepatoma cells. We have tested the activity of a separate and unique cytokine oncostatin M (OM) and have found potent APP-inducing activity of human recombinant OM on hepatocytes. OM acted in a dose-dependent fashion (ED50 5 to 10 ng/ml) in stimulating APP synthesis in human HepG2 cells, rat H35 cells, and primary rat hepatocyte cultures, but not human Hep3B cells. Human OM induced equivalent to or greater responses than IL-6 in HepG2 cells, however, it was less effective than human IL-6 in stimulating rat cells. Northern analysis showed that OM stimulated mRNA levels of haptoglobin and alpha 1-antichymotrypsin in HepG2 cells. OM induced CAT activity in HepG2 cells transfected with CAT constructs containing IL-6-responsive elements, suggesting that OM induces transcription of native proteins through mechanisms involving IL-6-responsive element-like sequences in gene promoters. OM was also shown to act additively with IL-6 or leukemia inhibitory factor and synergistically with glucocorticoid or IL-1 in the induction of specific APP. These results suggest that OM plays a role as a mediator of APP synthesis in inflammatory responses.
This article has been cited by other articles:
|
|
 |
|
  V. A. Luyckx, L. V. Cairo, C. A. Compston, W. L. Phan, and T. F. Mueller Oncostatin M pathway plays a major role in the renal acute phase response Am J Physiol Renal Physiol, April 1, 2009; 296(4): F875 - F883. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T.S.-C. Juan, B. Bolon, R. A. Lindberg, Y. Sun, G. Van, and F. A. Fletcher Mice Overexpressing Murine Oncostatin M (OSM) Exhibit Changes in Hematopoietic and Other Organs that Are Distinct from Those of Mice Overexpressing Human OSM or Bovine OSM Vet. Pathol., January 1, 2009; 46(1): 124 - 137. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Metcalf Hematopoietic cytokines Blood, January 15, 2008; 111(2): 485 - 491. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. D. Sorrells, S. D. Eicher, M. J. Harris, E. A. Pajor, and B. T. Richert Periparturient cortisol, acute phase cytokine, and acute phase protein profiles of gilts housed in groups or stalls during gestation J Anim Sci, July 1, 2007; 85(7): 1750 - 1757. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Boniface, C. Diveu, F. Morel, N. Pedretti, J. Froger, E. Ravon, M. Garcia, E. Venereau, L. Preisser, E. Guignouard, et al. Oncostatin M Secreted by Skin Infiltrating T Lymphocytes Is a Potent Keratinocyte Activator Involved in Skin Inflammation J. Immunol., April 1, 2007; 178(7): 4615 - 4622. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Diveu, E. Venereau, J. Froger, E. Ravon, L. Grimaud, F. Rousseau, S. Chevalier, and H. Gascan Molecular and Functional Characterization of a Soluble Form of Oncostatin M/Interleukin-31 Shared Receptor J. Biol. Chem., December 1, 2006; 281(48): 36673 - 36682. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. D. Sorrells, S. D. Eicher, K. A. Scott, M. J. Harris, E. A. Pajor, D. C. Lay Jr., and B. T. Richert Postnatal behavioral and physiological responses of piglets from gilts housed individually or in groups during gestation J Anim Sci, March 1, 2006; 84(3): 757 - 766. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. S. K. de Hooge, F. A. J. van de Loo, M. B. Bennink, D. S. de Jong, O. J. Arntz, E. Lubberts, C. D. Richards, and W. B. van den Berg Adenoviral Transfer of Murine Oncostatin M Elicits Periosteal Bone Apposition in Knee Joints of Mice, Despite Synovial Inflammation and Up-Regulated Expression of Interleukin-6 and Receptor Activator of Nuclear Factor-{kappa}B Ligand Am. J. Pathol., May 1, 2002; 160(5): 1733 - 1743. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Langdon, C. Kerr, M. Hassen, T. Hara, A. L. Arsenault, and C. D. Richards Murine Oncostatin M Stimulates Mouse Synovial Fibroblasts in Vitro and Induces Inflammation and Destruction in Mouse Joints in Vivo Am. J. Pathol., October 1, 2000; 157(4): 1187 - 1196. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. M. Hermanns, S. Radtke, C. Haan, H. Schmitz-Van de Leur, J. Tavernier, P. C. Heinrich, and I. Behrmann Contributions of Leukemia Inhibitory Factor Receptor and Oncostatin M Receptor to Signal Transduction in Heterodimeric Complexes with Glycoprotein 130 J. Immunol., December 15, 1999; 163(12): 6651 - 6658. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Fournier, N. Bouach, C. Delafosse, B. Crestani, and M. Aubier Inducible Expression and Regulation of the {alpha}1-Acid Glycoprotein Gene by Alveolar Macrophages: Prostaglandin E2 and Cyclic AMP Act as New Positive Stimuli J. Immunol., September 1, 1999; 163(5): 2883 - 2890. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. L. Reznikov, A. J. Puren, G. Fantuzzi, G. R. Hamner, U. S. Schwertschlag, J. L. Ryan, and C. A. Dinarello Suppression of endotoxin-inducible cytokines in whole blood from human subjects following single dose of recombinant human interleukin-11 Innate Immunity, August 1, 1999; 5(4): 197 - 204. [Abstract] [PDF]
|
|
|
|
|
|
A. Grenier, M. Dehoux, A. Boutten, M. Arce-Vicioso, G. Durand, M.-A. Gougerot-Pocidalo, and S. Chollet-Martin Oncostatin M Production and Regulation by Human Polymorphonuclear Neutrophils Blood, February 15, 1999; 93(4): 1413 - 1421. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Tanaka, T. Hara, N. G. Copeland, D. J. Gilbert, N. A. Jenkins, and A. Miyajima Reconstitution of the Functional Mouse Oncostatin M (OSM) Receptor: Molecular Cloning of the Mouse OSM Receptor beta Subunit Blood, February 1, 1999; 93(3): 804 - 815. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Crestani, C. Rolland, B. Lardeux, T. Fournier, D. Bernuau, C. Pous, C. Vissuzaine, L. Li, and M. Aubier Inducible Expression of the {alpha}1-Acid Glycoprotein by Rat and Human Type II Alveolar Epithelial Cells J. Immunol., May 1, 1998; 160(9): 4596 - 4605. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. I. Guillén, M. T. Donato, R. Jover, J. V. Castell, R. Fabra, R. Trullenque, and M. J. Gómez-Lechón Oncostatin M Down-regulates Basal and Induced Cytochromes P450 in Human Hepatocytes J. Pharmacol. Exp. Ther., April 1, 1998; 285(1): 127 - 134. [Abstract] [Full Text]
|
|
|
|
 |
|
 A. Boutten, P. Venembre, N. Seta, J. Hamelin, M. Aubier, G. Durand, and M. S. Dehoux Oncostatin M Is a Potent Stimulator of alpha 1-Antitrypsin Secretion in Lung Epithelial Cells: Modulation by Transforming Growth Factor-beta and Interferon-gamma Am. J. Respir. Cell Mol. Biol., April 1, 1998; 18(4): 511 - 520. [Abstract] [Full Text]
|
|
|
|
|
|
F. M. Botelho, D. R. Edwards, and C. D. Richards Oncostatin M Stimulates c-Fos to Bind a Transcriptionally Responsive AP-1 Element within the Tissue Inhibitor of Metalloproteinase-1 Promoter J. Biol. Chem., February 27, 1998; 273(9): 5211 - 5218. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Ichihara, T. Hara, H. Kim, T. Murate, and A. Miyajima Oncostatin M and Leukemia Inhibitory Factor Do Not Use the Same Functional Receptor in Mice Blood, July 1, 1997; 90(1): 165 - 173. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Auguste, C. Guillet, M. Fourcin, C. Olivier, J. Veziers, A. Pouplard-Barthelaix, and H. Gascan Signaling of Type II Oncostatin M Receptor J. Biol. Chem., June 20, 1997; 272(25): 15760 - 15764. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. K. Kuropatwinski, C. De Imus, D. Gearing, H. Baumann, and B. Mosley Influence of Subunit Combinations on Signaling by Receptors for Oncostatin M, Leukemia Inhibitory Factor, and Interleukin-6 J. Biol. Chem., June 13, 1997; 272(24): 15135 - 15144. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Korzus, H. Nagase, R. Rydell, and J. Travis The Mitogen-activated Protein Kinase and JAK-STAT Signaling Pathways Are Required for an Oncostatin M-responsive Element-mediated Activation of Matrix Metalloproteinase 1Gene Expression J. Biol. Chem., January 10, 1997; 272(2): 1188 - 1196. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Mosley, C. De Imus, D. Friend, N. Boiani, B. Thoma, L. S. Park, and D. Cosman Dual Oncostatin M (OSM) Receptors. CLONING AND CHARACTERIZATION OF AN ALTERNATIVE SIGNALING SUBUNIT CONFERRING OSM-SPECIFIC RECEPTOR ACTIVATION J. Biol. Chem., December 20, 1996; 271(51): 32635 - 32643. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C.-F. Lai, J. Ripperger, K. K. Morella, J. Jurlander, T. S. Hawley, W. E. Carson, T. Kordula, M. A. Caligiuri, R. G. Hawley, G. H. Fey, et al. Receptors for Interleukin (IL)-10 and IL-6-type Cytokines Use Similar Signaling Mechanisms for Inducing Transcription through IL-6 Response Elements J. Biol. Chem., June 14, 1996; 271(24): 13968 - 13975. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. L. Salvati, A. Lahm, G. Paonessa, G. Ciliberto, and C. Toniatti Interleukin-6 (IL-6) Antagonism by Soluble IL-6 Receptor [IMAGE] Mutated in the Predicted gp130-binding Interface J. Biol. Chem., May 19, 1995; 270(20): 12242 - 12249. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. C. Conover, N. Y. Ip, W. T. Poueymirou, B. Bates, M. P. Goldfarb, T. M. DeChiara, and G. D. Yancopoulos Ciliary neurotrophic factor maintains the pluripotentiality of embryonic stem cells Development, November 1, 1993; 119(3): 559 - 565. [Abstract] [PDF]
|
|
|
|
 |
|
 T Kishimoto, S Akira, and T Taga Interleukin-6 and its receptor: a paradigm for cytokines Science, October 23, 1992; 258(5082): 593 - 597. [Abstract] [PDF]
|
|
|
|
|
|
Y. Wang, O. Robledo, E. Kinzie, F. Blanchard, C. Richards, A. Miyajima, and H. Baumann Receptor Subunit-specific Action of Oncostatin M in Hepatic Cells and Its Modulation by Leukemia Inhibitory Factor J. Biol. Chem., August 11, 2000; 275(33): 25273 - 25285. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
